naltrexone has been researched along with Reperfusion Injury in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (43.75) | 29.6817 |
2010's | 8 (50.00) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Kang, P; Wang, HQ; Yang, J; Yang, P; Zhang, NL; Zhao, T | 1 |
Hisa, H; Mutoh, J; Ohsawa, M | 1 |
Guo, J; Li, M; Tian, X; Wu, G; Xia, Y; Zhu, M | 1 |
Cai, W; Li, J; Wang, J; Zhang, Y | 1 |
Mehal, WZ; Shaker, ME; Trawick, BN | 1 |
Abel, T; Chen, C; Liang, X; Liu, R; Ma, J; Su, D; Xi, C | 1 |
Guo, JC; Tian, XS; Wu, GC; Xia, Y; Yang, R; Zhou, F | 1 |
Cui, Q; Gu, CH; Guo, HT; Hui, B; Liang, C; Pei, JM; Peng, Z; Rong, F; Tao, C; Wang, YM; Ye, MX; Yi, DH; Yu, SQ; Zhang, QY; Zhang, SM; Zhao, Y | 1 |
Kim, JH; Kim, JI; Kim, TW; Kim, WY; Lee, YS; Min, TJ; Noh, KH; Park, YC | 1 |
Jeong, C; Jeong, H; Jeong, S; Kim, SJ; Lee, J; Lee, S; Yoo, KY | 1 |
Borlongan, CV; Kaneko, Y; Su, TP; Tajiri, N; Wang, Y | 1 |
Amanpour, S; Dehpour, AR; Ebrahimi, F; Hajrasouliha, AR; Jabehdar-Maralani, P; Mirkhani, SH; Shafaroodi, H; Tavakoli, S | 1 |
Ammon-Treiber, S; Höllt, V; Loh, H; Schröder, H; Stolze, D | 1 |
Chang, WL; Lee, SS; Su, MJ | 1 |
Chen, Z; Li, T; Zhang, B | 1 |
Sareen, D | 1 |
1 review(s) available for naltrexone and Reperfusion Injury
Article | Year |
---|---|
Neuroprotective agents in acute ischemic stroke.
Topics: Acute Disease; Adult; Aged; Animals; Antioxidants; Calcium Channel Blockers; Chlormethiazole; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Excitatory Amino Acid Antagonists; Excitatory Amino Acids; Forecasting; GABA Modulators; Guanidines; Humans; Imidazoles; Middle Aged; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Pipecolic Acids; Piperidines; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Reperfusion Injury; Stroke; Thiazoles | 2002 |
15 other study(ies) available for naltrexone and Reperfusion Injury
Article | Year |
---|---|
Effects of nalmefene hydrochloride on TLR4 signaling pathway in rats with lung ischemia-reperfusion injury.
Topics: Acute Lung Injury; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Naltrexone; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Signal Transduction; Thoracotomy; Toll-Like Receptor 4 | 2020 |
Effect of naloxone on ischemic acute kidney injury in the mouse.
Topics: Analgesics, Opioid; Animals; Dose-Response Relationship, Drug; Hypothalamus, Anterior; Injections, Intraperitoneal; Injections, Intraventricular; Kidney; Male; Mice; Mice, Inbred ICR; Molecular Targeted Therapy; Naloxone; Naltrexone; Narcotic Antagonists; Nerve Tissue Proteins; Neurons; Proto-Oncogene Proteins c-fos; Receptors, Opioid, mu; Renal Insufficiency; Reperfusion Injury | 2013 |
δ-Opioid receptor activation rescues the functional TrkB receptor and protects the brain from ischemia-reperfusion injury in the rat.
Topics: Activating Transcription Factor 1; Animals; Blotting, Western; Brain; Brain Ischemia; Brain-Derived Neurotrophic Factor; CD11b Antigen; Cerebrovascular Circulation; Cyclic AMP Response Element-Binding Protein; Infarction, Middle Cerebral Artery; Male; Naltrexone; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, trkB; Receptors, Opioid, delta; Reperfusion Injury | 2013 |
[κ-opioid receptor agonist U50, 488H attenuates myocardial ischemia-reperfusionvia modulating Toll-like receptor 4/nuclear factor-κB signaling in rat].
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Arrhythmias, Cardiac; Brugada Syndrome; Cardiac Conduction System Disease; Coronary Artery Disease; Down-Regulation; Heart Conduction System; Myocardial Infarction; Myocardial Ischemia; Myocardium; Naltrexone; NF-kappa B; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reperfusion Injury; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha | 2014 |
The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers.
Topics: Animals; Dendritic Cells; Diet, High-Fat; Fatty Liver; Liver; Liver Function Tests; Macrophages, Peritoneal; Male; Mice, Inbred C57BL; Naltrexone; Reperfusion Injury; Toll-Like Receptor 9 | 2016 |
The Role of κ Opioid Receptor in Brain Ischemia.
Topics: Animals; Apoptosis; Blotting, Western; Brain Ischemia; Disease Models, Animal; Diterpenes, Clerodane; Male; Mice; Mice, Inbred C57BL; Naltrexone; Receptors, Opioid, kappa; Reperfusion Injury | 2016 |
[Effects of intracerebroventricular injection of delta-opioid receptor agonist TAN-67 or antagonist naltrindole on acute cerebral ischemia in rat].
Topics: Animals; Brain; Brain Ischemia; Infarction, Middle Cerebral Artery; Injections, Intraventricular; Naltrexone; Quinolines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, delta; Reperfusion Injury | 2008 |
Myocardial apoptosis and infarction after ischemia/reperfusion are attenuated by kappa-opioid receptor agonist.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Antihypertensive Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 9; DNA Fragmentation; Male; Microscopy, Electron, Transmission; Myocardial Infarction; Myocardium; Naltrexone; Narcotic Antagonists; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Reperfusion Injury | 2009 |
Morphine postconditioning attenuates ICAM-1 expression on endothelial cells.
Topics: Animals; Benzophenanthridines; Endothelial Cells; Endothelium, Vascular; Humans; Intercellular Adhesion Molecule-1; Morphine; Naloxone; Naltrexone; Narcotic Antagonists; Narcotics; Protein Isoforms; Protein Kinase C; Receptors, Opioid; Reperfusion Injury; Signal Transduction; Umbilical Veins | 2011 |
Neuroprotective effects of remifentanil against transient focal cerebral ischemia in rats.
Topics: Anesthetics, Intravenous; Animals; Blood Pressure; Blotting, Western; Carbon Dioxide; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; Interleukin-6; Ischemic Attack, Transient; Male; Mitogen-Activated Protein Kinases; Naltrexone; Narcotic Antagonists; Nervous System Diseases; Neuroprotective Agents; Piperidines; Rats; Rats, Sprague-Dawley; Remifentanil; Reperfusion Injury; Tumor Necrosis Factor-alpha | 2012 |
Combination treatment of hypothermia and mesenchymal stromal cells amplifies neuroprotection in primary rat neurons exposed to hypoxic-ischemic-like injury in vitro: role of the opioid system.
Topics: Analgesics, Opioid; Animals; Cell Survival; Cell- and Tissue-Based Therapy; Glucose; HEK293 Cells; Humans; Hypothermia, Induced; Intellectual Disability; Lennox Gastaut Syndrome; Mesenchymal Stem Cells; Mitochondria; Naltrexone; Neurons; Neuroprotective Agents; Oxygen; Rats; Receptors, Opioid, delta; Reperfusion Injury; Spasms, Infantile | 2012 |
Cholestatic liver disease modulates susceptibility to ischemia/reperfusion-induced arrhythmia, but not necrosis and hemodynamic instability: the role of endogenous opioid peptides.
Topics: Animals; Arrhythmias, Cardiac; Blood Pressure; Cholestasis, Intrahepatic; Electrocardiography; Heart Rate; Hemodynamics; Male; Myocardial Infarction; Naltrexone; Necrosis; NG-Nitroarginine Methyl Ester; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2005 |
Effects of opioid antagonists and morphine in a hippocampal hypoxia/hypoglycemia model.
Topics: Analgesics, Opioid; Animals; Brain Chemistry; Evoked Potentials; Hippocampus; Hypoglycemia; Hypoxia, Brain; In Vitro Techniques; Male; Morphine; Naltrexone; Narcotic Antagonists; Neuroprotective Agents; Neurotoxicity Syndromes; Rats; Rats, Wistar; Reperfusion Injury | 2005 |
Attenuation of post-ischemia reperfusion injury by thaliporphine and morphine in rat hearts.
Topics: Adenosine Triphosphate; Analgesics, Opioid; Animals; Antioxidants; Aporphines; Creatine Kinase; Dose-Response Relationship, Drug; Heart; Male; Mitochondria; Morphine; Myocardial Ischemia; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Peroxidase; Plant Extracts; Potassium; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Risk; Time Factors | 2005 |
Morphine postconditioning protects against reperfusion injury in the isolated rat hearts.
Topics: Analgesics, Opioid; Animals; Anti-Arrhythmia Agents; Cardiotonic Agents; Decanoic Acids; Dose-Response Relationship, Drug; Hydroxy Acids; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Male; Morphine; Myocardial Infarction; Naloxone; Naltrexone; Narcotic Antagonists; Potassium Channels; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2008 |